在乌干达引入疟疾疫苗的成本和预算影响
Perez N Ochanda1, Elizabeth Ekirapa-Kiracho2, Chrispus Mayora2
1Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; Department of Health Policy Planning and Management, School of Public Health, Makerere University, Kampala, Uganda.
Value in health regional issues
|March 15, 2026
概括
在乌干达引入RTS,S/AS01疟疾疫苗将大大增加卫生预算,估计在五年内耗资1.41亿美元. 优先考虑资金和有针对性的战略对于可持续的疟疾预防至关重要.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 世界卫生组织建议RTS,S/AS01疟疾疫苗用于高负担地区.
- 疟疾疫苗的可负担性仍然是低资源环境中的挑战,阻碍了广泛采用.
研究的目的:
- 研究将RTS,S/AS01疟疾疫苗引入乌干达国家免疫计划的成本和预算影响.
主要方法:
- 通过乌干达和撒哈拉以南非洲的前性数据进行了预算影响分析.
- 单位成本来源于现有文献,疟疾病例被避免作为主要结果.
- 敏感性分析探讨了不同的疫苗覆盖率和疟疾发病率水平.
主要成果:
- 据估计,每年的疫苗接种成本为2900万美元,占乌干达免疫预算的24%.
- 在五年内,总预算影响为1.455亿美元,净成本为1.41亿美元.
- 预算影响随着覆盖范围的波动而波动,从1.063亿美元到1.756亿美元.
结论:
- 疟疾疫苗的实施需要大幅增加乌干达的免疫和整体卫生部门预算.
- 优先考虑政府资金和采用具有成本效益的战略,如针对高传播区域,对于可持续性和可负担性至关重要.
相关概念视频
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...